Key highlights

  • Papyrus Australia shares traded at $0.011 at 11:04 AM AEDT on 19 November 2026, up 22.22%, while the S&P/ASX 200 was up 0.83% around midday.
  • The company signed Variation No. 2 with TBS Mining Solutions, and the first Collar Keeper product has been accepted for commercial supply.
  • The first product represents 25% of the contract minimum volumes, with the total contract valued at about $4.2 million at the initial base price.

Shares in Papyrus Australia Limited (ASX:PPY) were trading at $0.011 during the session on 19 November 2026, up 22.22% at 11:04 AM AEDT, while the S&P/ASX 200 was up 0.83% at 8,748.30 around midday. Papyrus is an Adelaide-based company developing biodegradable products, and its Collar Keeper range is being commercialised through a contract with TBS Mining Solutions, a Subsidiary of Aquirian Limited (ASX:AQN). In an announcement dated 18 November 2026, Papyrus said it had signed Variation No. 2 to that contract after the first product in the range was accepted by TBS for commercial supply.

Phased Acceptance of the Product Range

Under the variation, each product in the Collar Keeper range is accepted once Papyrus and TBS sign off its specification, performance, use conditions and price. A joint technical working group will coordinate development, testing and field trials. The first product has been accepted after certification testing, and TBS has placed an initial order that the company describes as not material in value. Each accepted product adds its agreed share of the contract minimum purchase volumes, so the minimums grow as the range is accepted.

Revised Timetable and Production Facility

Papyrus is progressing production equipment at its Adelaide facility, and it will use reasonable endeavours to commission that equipment within six months of signing. Minimum purchases will now start two months after the company issues a Production Ready Notice, replacing the 1 March 2027 start date set under the earlier variation. Until then, TBS may order up to an agreed monthly Volume with no minimum, supplied through the existing Supply chain. The company says the next priority product represents a further 25% of contract volumes.

Sector Context

Biodegradable consumables are a niche area within industrial supply, where products often need testing for the field conditions in which they will be used. The company has said testing has shown that each product is best tested for its own use environment, which is why the acceptance process has moved to a product-by-product approach.

Risks Investors Are Watching

The first product represents about $1.05 million of minimum volumes at the initial base price if it stays at 25% for all three minimum years, but the company describes this as neither a forecast nor guaranteed revenue. Minimum purchases depend on the production facility, funding, permits and the contract continuing. TBS may end the contract without an exit fee if the timetable conditions in the variation are not met.

What to Watch Ahead

The company is aiming to bring the rest of the range to market in stages during the first half of 2027, while it completes its production facility. Investors will be watching the production ready notice, the acceptance of the next product and the order flow from TBS once minimum purchases begin.

About the Company

Papyrus Australia Limited is an ASX-listed company based in Adelaide that is developing biodegradable products for industrial applications. Its Biodegradable Collar Keeper range is being commercialised through a supply contract with TBS Mining Solutions Pty Ltd, a Wholly Owned Subsidiary of Aquirian Limited (ASX:AQN). The original contract was signed on 27 November 2025 and was announced on 28 November 2025. The parties have since varied it, first to update the project timetable and then, in the latest variation, to introduce a phased approach to testing and acceptance. Papyrus is progressing its production equipment at the Adelaide facility, and minimum purchases under the contract depend on that Facility becoming production ready. Each product in the range carries an agreed share of the minimum purchase volumes, so the contract value grows as products are accepted.

Session Context

The shares were trading at $0.011 during the session on 19 November 2026, up 22.22% at 11:04 AM AEDT. These are intraday figures rather than a closing price, so the move reflects trade in progress at that time. Over the same period the S&P/ASX 200 was up 0.83% at 8,748.30 around midday. In the previous session on 18 November, the Dow Jones closed down 1.32% and the Nasdaq closed down 0.02%.

Closing Note

Papyrus shares rose in mid-morning trade on 19 November 2026. Progress on the production facility and the acceptance of the next product will set the pace of the commercial rollout.